Antisense News and Research

RSS
Antisense is the non-coding strand in double-stranded DNA. The antisense strand serves as the template for mRNA synthesis.
AACR and MPM award three grants to support groundbreaking cancer research projects

AACR and MPM award three grants to support groundbreaking cancer research projects

Designer DNA agent reduces myeloma stem cell abundance, lowers disease burden in mice

Designer DNA agent reduces myeloma stem cell abundance, lowers disease burden in mice

Researchers develop ultra-small nanomedicines to target intractable cancers

Researchers develop ultra-small nanomedicines to target intractable cancers

Replacing the RNA strand with DNA may enhance efficacy of ASO-based drugs

Replacing the RNA strand with DNA may enhance efficacy of ASO-based drugs

A paper-based sensor for detecting COVID-19

A paper-based sensor for detecting COVID-19

FDA takes first steps in bringing clarity to emerging area of individualized drug development

FDA takes first steps in bringing clarity to emerging area of individualized drug development

Gene-regulating snippet of RNA may contribute to breast cancer metastasis

Gene-regulating snippet of RNA may contribute to breast cancer metastasis

Paper-based electrochemical sensor can enable rapid detection of SARS-CoV-2

Paper-based electrochemical sensor can enable rapid detection of SARS-CoV-2

Adding exercise to genetic treatment reverses fatigue in mice with common myotonic dystrophy

Adding exercise to genetic treatment reverses fatigue in mice with common myotonic dystrophy

Peptide-conjugated morpholino oligomers effectively inhibit SARS-CoV-2 in vero cells

Peptide-conjugated morpholino oligomers effectively inhibit SARS-CoV-2 in vero cells

SARS-CoV-2 RNA genome structure reveals potential targets for development of drugs

SARS-CoV-2 RNA genome structure reveals potential targets for development of drugs

RNA-binding proteins may suppress antiviral defenses against SARS-CoV-2

RNA-binding proteins may suppress antiviral defenses against SARS-CoV-2

Research projects receive BTCA grants to develop novel drugs for various diseases

Research projects receive BTCA grants to develop novel drugs for various diseases

Inhibition of SARS-CoV-2 with antisense oligonucleotides

Inhibition of SARS-CoV-2 with antisense oligonucleotides

Research underlines SARS-CoV-2 N-terminal domain of Nsp1 as a potential drug target

Research underlines SARS-CoV-2 N-terminal domain of Nsp1 as a potential drug target

Investigational drug may reduce protein buildup and neurological decline linked to ALS, FTD

Investigational drug may reduce protein buildup and neurological decline linked to ALS, FTD

Evidence of SARS-CoV-2 coronavirus particles in heart tissue

Evidence of SARS-CoV-2 coronavirus particles in heart tissue

Faulty RNA quality control system leads to haywire production of toxic proteins in FTLD/ALS

Faulty RNA quality control system leads to haywire production of toxic proteins in FTLD/ALS

Researchers identify new mechanism that causes leukemia

Researchers identify new mechanism that causes leukemia

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation